Lapatinib Completed Phase 2 Trials for Recurrent Prostate Cancer / Stage IV Prostate Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00095667Lapatinib in Treating Patients With Recurrent or Metastatic Prostate Cancer